Streamline disease modeling and therapeutic discovery with targeted viral vectors

Abhilasha Gupta

30 July 2025

Register

Exploring scalable, data-driven AAV manufacturing to achieve high yield and quality across serotypes

Xiaojun Liu, Chris Brown, Yeonji Kim

23 July 2025

Register

Future-proofing gene therapy: scalable AAV solutions and non-viral innovations

Vijetha Bhat

10 July 2025

Register

Learn how to design a simplified, cost-effective LVV manufacturing workflow

Nicole Votaw, Thomas Robert, Shameer Subratty

08 July 2025

Register

Exploring key regulatory considerations to ensure patient safety in the gene therapy space

L Shaw, C Le Bec, M Orio et al

01 July 2025

Register

Exploring the advantages of ready-to-use lipid-based gene delivery for gene-modified cell therapy

Chesney Michels, Claire Guéguen

25 June 2025

Watch

Enabling early AAV characterization: the role of mass photometry in upstream process development

Maria Jacintha Victoria

24 June 2025

Watch

Making robust choices: evaluating materials in your AAV process

Michael Bodo, Birgit Rogell

18 June 2025

Watch

Optimizing plasmid DNA purification: strategies for reliable and expandable processes

Christy Franco, Jasmina Puc

17 June 2025

Watch

Key considerations for scalable retroviral vector production—with a focus on lentivirus

Alex Chatel

16 June 2025

Interview

Case study: establishing a versatile and intensified lentiviral vector production platform with TFDF

Chris Brown

28 May 2025

Watch

Find the EV needle in the haystack with Leprechaun

Kevin Lance

22 May 2025

Watch

Revolutionizing non-viral gene delivery with silicon-stabilized LNPs

Suzanne Saffie-Siebert

20 May 2025

Interview

Exploring innovations in AAV upstream processing to advance gene therapy development

Hao Liu

08 May 2025

Interview

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel

14 April 2025

Interview

Achieving high-titer rAAV production with significantly reduced encapsidated host cell DNA

Ines Goncalves

10 April 2025

Watch

Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee

09 April 2025

Watch

Advancing quality standards for gene therapies: a USP perspective

Fouad Atouf

08 April 2025

Interview

Transforming viral vector manufacturing with next-generation CGMP plasmids platform

John Bowen, Brian Tomkowicz

02 April 2025

Watch

Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing

Rob Noel, Geddy Hamblen, Christel Fenge

01 April 2025

Watch

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek

26 March 2025

Innovator Insight